跳至主要内容
临床试验/IRCT20210809052117N1
IRCT20210809052117N1尚未招募3 期

Effect of Empagliflozin on clinical and echocardiographic parameters in non diabetic patient with reduced LVEF heart failure

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 44 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Age: 18 yr_80 yr
  • Heart failure with reduced EF <40%
  • Nondiabetic
  • Stable symptom and therapy for heart failure

排除标准

  • Cardiovascular event, admission for cardiovascular or renal complications within last 3 months
  • Cancer or life-threatening condition
  • Estimated GFR < 45 ml/min/m2
  • Systolic blood pressure < 90mmhg
  • Pregnancy or lactating women

研究者

相似试验

进行中(未招募)
1 期
Impact of Empagliflozin on heart in patients with myocardial infarctioMyocardial infarction
EUCTR2016-004591-22-ATMedical University of Graz/Department of Internal Medicine/Division of Endocrinology and Diabetology476
尚未招募
2 期
Efficacy of Empagliflozin on cardiac function in non- diabetic patients after primary percutaneous angioplasty on left anterior descending coronary arteryacute myocardial infarction.121-09
IRCT20200727048226N1Tehran University of Medical Sciences88
进行中(未招募)
1 期
Effects of empagliflozin on cardiac remodeling and myocardial sympathetic nervous system in diabetic patients affected by chronic heart failurediabetes mellitus and heart failureMedDRA version: 20.0Level: LLTClassification code 10011949Term: Decompensation cardiacSystem Organ Class: 100000004849
EUCTR2019-002202-43-ITAOU FEDERICO II34
尚未招募
4 期
To Study the effect of Empagliflozin on the cardiovascular biomarkers in diabetic patients myocardial infarctioCondition 1: Myocardial Infarction. Condition 2: Type 2 diabetes.Acute transmural myocardial infarction of unspecified siteType 2 diabetes mellitus without complicationsI21.3E11.9
IRCT20230724058910N1Zanjan University of Medical Sciences60
招募中
2 期
The effect of Empagliflozin on left ventricular ejection fraction in non-diabetic patients with acute anterior ST elevation Myocardial infarction treated with primary PCIAcute anterior ST elevation Myocardial infarction treated with primary PCI.ST elevation (STEMI) myocardial infarction of anterior wallI21.0
IRCT20221227056950N1Mashhad University of Medical Sciences64
Effect of Empagliflozin on clinical and... | 临床试验